| Company Name: |
Alta Scientific Co., Ltd.
|
| Tel: |
022-6537-8550 15522853686 |
| Email: |
sales@altasci.com.cn |
| Products Intro: |
Product Name:Norethindrone-13C2
CAS:201741-02-8
Purity:99% Package:10mg;100mg;1g
|
| Company Name: |
ShangHai Anpel Co, Ltd.
|
| Tel: |
18017382783 18017382783 |
| Email: |
shanpel@anpel.com.cn |
| Products Intro: |
Product Name:Norethindrone-[13C2
CAS:201741-02-8
Purity:100ppm Package:100mg/L于甲醇，1.2ml Remarks:CDAA-S-590159C2-AA-1.2ml
|
| Company Name: |
Reer Technology (Shanghai) Co., LTD
|
| Tel: |
021-64400900 15800436310 |
| Email: |
bessey@reertech.com |
| Products Intro: |
Product Name:NORETHINDRONE(ETHYNYL-13C2, 99%)
CAS:201741-02-8
Purity:98% Package:0.01 G Remarks:CLM-2468-0.01
|
| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:Norethindrone (Ethynyl-13C2)
CAS:201741-02-8
Purity:95% Package:1mg;5mg
|
Norethindrone-13C2 Solution, 100ppm manufacturers
|
| | Norethindrone-13C2 Solution, 100ppm Basic information |
| | Norethindrone-13C2 Solution, 100ppm Chemical Properties |
| | Norethindrone-13C2 Solution, 100ppm Usage And Synthesis |
| Uses | Norethindrone-13C2 (Norethisterone-13C2) is the 13C labeled Norethindrone (HY-B0554)[1]. Norethindrone is a female progestin approved by FDA for the treatment of endometriosis, uterine bleeding caused by abnormal hormone levels, and secondary amenorrhea[2][3][4][5]. | | References | [1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. DOI:10.1177/1060028018797110
[2] Muneyyirci-Delale O, et al. Effect of norethindrone acetate in the treatment of symptomatic endometriosis. Int J Fertil Womens Med. 1998 Jan-Feb;43(1):24-7. PMID:9532466
[3] Kaser DJ, et al. Use of norethindrone acetate alone for postoperative suppression of endometriosis symptoms. J Pediatr Adolesc Gynecol. 2012 Apr;25(2):105-8. DOI:10.1016/j.jpag.2011.09.013
[4] Maier WE, et al. Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals. Regul Toxicol Pharmacol. 2001 Aug;34(1):53-61. DOI:10.1006/rtph.2001.1483
[5] Cheng DC, et al. Norethindrone acetate inhibition of triglyceride synthesis and release by rat hepatocytes. Atherosclerosis. 1983 Jan;46(1):41-8. DOI:10.1016/0021-9150(83)90162-4 |
| | Norethindrone-13C2 Solution, 100ppm Preparation Products And Raw materials |
|